Additional Value of [18F]FDG PET/CT in Detection of Suspected Malignancy in Patients with Paraneoplastic Neurological Syndromes Having Negative Results of Conventional Radiological Imaging.
Marta OpalińskaAnna Sowa-StaszczakKamil WężykJeremiasz JagiełłaAgnieszka SłowikAlicja Hubalewska-DydejczykPublished in: Journal of clinical medicine (2022)
[18F]FDG PET/CT may be considered as a useful tool for neoplastic tumor detection in patients with paraneoplastic neurological syndromes, accelerating the diagnostic process and enabling faster initiation of appropriate treatment.